Taiko Pharmaceutical Co (TSE:4574) Inventories, Finished Goods : 円417 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Taiko Pharmaceutical Co Inventories, Finished Goods?

Taiko Pharmaceutical Co's quarterly finished goods declined from Sep. 2023 (円480 Mil) to Dec. 2023 (円421 Mil) and declined from Dec. 2023 (円421 Mil) to Mar. 2024 (円417 Mil).

Taiko Pharmaceutical Co's annual finished goods increased from Mar. 2020 (円1,346 Mil) to Dec. 2021 (円2,010 Mil) but then declined from Dec. 2021 (円2,010 Mil) to Dec. 2022 (円696 Mil).

Taiko Pharmaceutical Co Inventories, Finished Goods Historical Data

The historical data trend for Taiko Pharmaceutical Co's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiko Pharmaceutical Co Inventories, Finished Goods Chart

Taiko Pharmaceutical Co Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Dec21

Dec22

Inventories, Finished Goods

Get a 7-Day Free Trial

834.08

878.69

1,346.24

2,010.00

696.00

Taiko Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															723.00	736.00	480.00	421.00	417.00

Taiko Pharmaceutical Co Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Taiko Pharmaceutical Co (TSE:4574) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taiko Pharmaceutical Co Ltd (TSE:4574) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 34 Third Street, No. 14, Uchihon Suita, Osaka, JPN, 564-0032

Website

http://www.seirogan.co.jp

Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.

Taiko Pharmaceutical Co (TSE:4574) Headlines

No Headlines